Comprehensive panels
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes, including relevant cancer biomarkers, for biomarker discovery and other research aims.
Streamline precision oncology with Illumina Connected Insights
Comprehensive insights and automation to support somatic oncology variant interpretation and reporting for any assay, at any scale
Your email address is never shared with third parties.
Illumina Connected Insights is a powerful software enabling AI-assisted variant interpretation and reporting of next-generation sequencing (NGS) data. Harnessing globally-recognized knowledge sources and ingesting data from a wide range of oncology assays, Connected Insights is precision-engineered to enhance accuracy of results and accelerate reporting.
Unify your knowledge sources in one powerful solution and streamline interpretation with customizable automation. Reduce your variant review lists by up to 90%*.
Remove unnecessary touchpoints and move from sequencing through draft report faster. Seamless compatibility with Illumina assays, instruments, and software, including DRAGEN secondary analysis—winner of the FDA Truth Challenge.
Keep pace with the latest science and future-proof your lab. Ingest data from any assay, at any scale. Access the latest innovations in variant calling, Illumina proprietary AI algorithms, and visualizations.
Generate insights from 55+ knowledge sources including the Clinical Knowledgebase (CKB) from Genomenon, CiVIC, and OncoKB. Prioritize relevant clinical trials, drug labels, and guidelines within a single environment.
Generate gene- and exon-level visualizations for DNA and RNA, variant QC, genome plots for structural variants, Circos plots, B-allele ratio, fusion plots, and more.
From data upload, automated guidelines-based oncogenicity classification, to report generation – configure your settings and automate for a streamlined experience with minimum touchpoints.
Evolve with confidence across assays and applications—from panels to genomes and transcriptomes, from tissue to liquid biopsy and heme.
Configure regional content, preferences and language to meet regional needs.
Employ security-first infrastructure and conform to privacy and compliance software requirements and regulations.
Identify key DNA variant types (SVs, MNVs, exon-level CNVs, indels, fusions, tandem repeats, LOH) relevant in multiple disease types and across a variety of NGS assays.
Analyze variants from RNA or transcriptomics (fusions, splice variants, and soon expression levels) to gain a deeper and more comprehensive understanding of malignancies.
Uncover more insights by interpreting genome- wide pan-cancer biomarker signatures (TMB, MSI, HRD) with increasing relevance to precision medicine.
Deepen your insights with cutting-edge visualizations –explore genome view, DNA and RNA coverage plots, variant allele frequency (VAF), fusion plots, and more.
Leverage proprietary Illumina AI algorithms and pull from a comprehensive set of sources (including previously curated variants) as predictors to automatically calculate the oncogenicity classification score of relevant variants.
Automatically detect hematological cancer subtypes based on key guidelines, leveraging interactive evidence maps and automated report summaries.
Prepare libraries for somatic oncology panels, CGP, or other compatible applications.
Sequence libraries using any Illumina or other sequencing platform.
Call variants with DRAGEN or other secondary analysis tools to generate VCF (Variant Call Format) output.
Ingest VCF files to Connected Insights to enable generation of insights and case reporting.
Tertiary analysis software can help address the bottleneck for somatic oncology variant interpretation. Learn key considerations and best practices for implementing a streamlined workflow.
Your email address is never shared with third parties.
Directly integrated within the Illumina Connected Software ecosystem, Connected Insights on the cloud unifies highly scalable data management and processing with an enterprise-level data privacy and security all within a single environment. A direct integration option with DRAGEN for variant calling is seamless and automated.
Accessed via a DRAGEN server, Connected Insights-Local supports customers in environments where access to the cloud is not an option. Connected Insights on-premises allows users to directly pair DRAGEN secondary analysis with Connected Insights, offering a solution for local somatic oncology variant calling and interpretation.
Read about the joint power of DRAGEN and Connected Insights-Local:
To meet the most stringent security requirements, Illumina Connected Insights platform is built with security and compliance at its core. Read the security brief for more details.
Read how Connected Insights streamlines, integrates, and powers molecular laboratories for scale and growth.
Watch this video to understand how you can connect various knowledge sources to streamline data interpretation operations for critical insights.
Discover how Connected Insights can streamline user-defined variant interpretation research workflows and reduce to research report, all within a single environment.
Learn how Connected Insights employs key security and privacy features to protect sensitive NGS data.
Find out more about how Illumina informatics enables the most accurate and comprehensive workflow on the market for oncology NGS.
he Jackson Laboratory scales their genetic discovery and molecular profiling services for cancer neurogenomics, adopting Illumina Connected Insights as part of an end-to-end Illumina informatics workflow.
Jing Gao, VP of Illumina Informatics, speaks to Illumina’s vision for oncology informatics.
View the software resources page for the latest release information and other news.
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes, including relevant cancer biomarkers, for biomarker discovery and other research aims.
Focus on sequencing coding regions, which frequently contain mutations that affect tumor progression, for a cost-effective approach.
Get a genome-wide view of somatic mutations and other genomic alterations present in cancer tissue and discover novel cancer-associated variants.
Discuss your workflow to learn how you can streamline your NGS operations and power your lab for growth using Illumina Connected Insights.
Your email address is never shared with third parties.
References